Anthony Vendetti
Stock Analyst at Maxim Group
(3.83)
# 730
Out of 4,711 analysts
72
Total ratings
29.03%
Success rate
18.35%
Average return
Main Sectors:
Stocks Rated by Anthony Vendetti
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BHST BioHarvest Sciences | Initiates: Buy | $12 | $6.29 | +90.78% | 1 | Dec 18, 2024 | |
| ACON Aclarion | Downgrades: Hold | n/a | $0.12 | - | 2 | Dec 13, 2024 | |
| NXL Nexalin Technology | Downgrades: Hold | n/a | $2.63 | - | 2 | Dec 5, 2024 | |
| TNON Tenon Medical | Maintains: Buy | $22 → $8 | $1.84 | +334.78% | 1 | Nov 15, 2024 | |
| SRTS Sensus Healthcare | Maintains: Buy | $12 → $14 | $7.10 | +97.18% | 5 | Nov 15, 2024 | |
| NUTX Nutex Health | Maintains: Buy | $45 → $50 | $29.38 | +70.18% | 2 | Nov 12, 2024 | |
| HSDT Helius Medical Technologies | Downgrades: Hold | n/a | $0.91 | - | 2 | Oct 16, 2024 | |
| CELH Celsius Holdings | Maintains: Buy | $65 → $50 | $27.01 | +85.12% | 7 | Sep 5, 2024 | |
| DRMA Dermata Therapeutics | Maintains: Buy | $10 → $6 | $1.08 | +455.56% | 3 | Aug 21, 2024 | |
| BIAF bioAffinity Technologies | Initiates: Buy | $6 | $0.99 | +504.35% | 1 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.38 | - | 2 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $15 | $6.42 | +133.64% | 6 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $0.85 | +605.88% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $7.45 | +34.23% | 1 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.08 | +140.38% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $0.36 | +733.33% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $10.27 | - | 4 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $2 | $6.18 | -67.64% | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $2.06 | +5,967.96% | 1 | Apr 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $7 | $1.07 | +554.21% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.36 | - | 3 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $25 | $42.25 | -40.83% | 1 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $420 → $490 | $0.99 | +49,590.70% | 1 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.32 | - | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $140 | $0.24 | +58,797.77% | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $5 | $2.52 | +98.41% | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.58 | - | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $1.12 | +167.86% | 1 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $17.98 | - | 2 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $160 | $0.18 | +90,244.44% | 3 | Nov 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | n/a | $45.37 | - | 3 | Jun 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $792 → $720 | $0.87 | +82,658.62% | 2 | Aug 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $10.09 | -50.45% | 1 | Jan 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.32 | - | 1 | May 31, 2016 |
BioHarvest Sciences
Dec 18, 2024
Initiates: Buy
Price Target: $12
Current: $6.29
Upside: +90.78%
Aclarion
Dec 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.12
Upside: -
Nexalin Technology
Dec 5, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.63
Upside: -
Tenon Medical
Nov 15, 2024
Maintains: Buy
Price Target: $22 → $8
Current: $1.84
Upside: +334.78%
Sensus Healthcare
Nov 15, 2024
Maintains: Buy
Price Target: $12 → $14
Current: $7.10
Upside: +97.18%
Nutex Health
Nov 12, 2024
Maintains: Buy
Price Target: $45 → $50
Current: $29.38
Upside: +70.18%
Helius Medical Technologies
Oct 16, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.91
Upside: -
Celsius Holdings
Sep 5, 2024
Maintains: Buy
Price Target: $65 → $50
Current: $27.01
Upside: +85.12%
Dermata Therapeutics
Aug 21, 2024
Maintains: Buy
Price Target: $10 → $6
Current: $1.08
Upside: +455.56%
bioAffinity Technologies
Jul 23, 2024
Initiates: Buy
Price Target: $6
Current: $0.99
Upside: +504.35%
Jul 17, 2024
Downgrades: Hold
Price Target: n/a
Current: $4.38
Upside: -
May 9, 2024
Maintains: Buy
Price Target: $18 → $15
Current: $6.42
Upside: +133.64%
Jan 30, 2024
Initiates: Buy
Price Target: $6
Current: $0.85
Upside: +605.88%
Dec 20, 2023
Initiates: Buy
Price Target: $10
Current: $7.45
Upside: +34.23%
Oct 5, 2023
Initiates: Buy
Price Target: $5
Current: $2.08
Upside: +140.38%
Oct 5, 2023
Initiates: Buy
Price Target: $3
Current: $0.36
Upside: +733.33%
Aug 11, 2023
Downgrades: Hold
Price Target: n/a
Current: $10.27
Upside: -
May 25, 2023
Initiates: Buy
Price Target: $2
Current: $6.18
Upside: -67.64%
Apr 20, 2023
Initiates: Buy
Price Target: $125
Current: $2.06
Upside: +5,967.96%
Mar 31, 2023
Maintains: Buy
Price Target: $12 → $7
Current: $1.07
Upside: +554.21%
Mar 30, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.36
Upside: -
Mar 29, 2023
Maintains: Buy
Price Target: $15 → $25
Current: $42.25
Upside: -40.83%
Mar 29, 2023
Maintains: Buy
Price Target: $420 → $490
Current: $0.99
Upside: +49,590.70%
Mar 28, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.32
Upside: -
Mar 23, 2023
Maintains: Buy
Price Target: $240 → $140
Current: $0.24
Upside: +58,797.77%
Nov 15, 2022
Maintains: Buy
Price Target: $13 → $5
Current: $2.52
Upside: +98.41%
Nov 15, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.58
Upside: -
Oct 25, 2022
Initiates: Buy
Price Target: $3
Current: $1.12
Upside: +167.86%
Sep 21, 2022
Downgrades: Hold
Price Target: n/a
Current: $17.98
Upside: -
Nov 22, 2019
Upgrades: Buy
Price Target: $160
Current: $0.18
Upside: +90,244.44%
Jun 3, 2019
Upgrades: Hold
Price Target: n/a
Current: $45.37
Upside: -
Aug 16, 2018
Maintains: Buy
Price Target: $792 → $720
Current: $0.87
Upside: +82,658.62%
Jan 26, 2017
Upgrades: Buy
Price Target: $5
Current: $10.09
Upside: -50.45%
May 31, 2016
Downgrades: Hold
Price Target: n/a
Current: $0.32
Upside: -